Characterization of insulin-like growth factors and their binding proteins in peritoneal dialysate

Arundhati S. Kale, Frances Liu, Raymond L. Hintz, Bonita K. Baker, Eileen D. Brewer, Phillip Lee, Susan K. Durham, David R. Powell

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Serum insulin-like growth factors (IGFs), which circulate bound to specific IGF binding proteins (IGFBPs), must exit the intravascular space before acting on target tissues. Little is known about the nature of IGF/IGFBPs in extravascular fluids of patients with chronic renal failure (CRF). Peritoneal dialysate (PD) was studied since, after a short incubation, PD contains proteins which have entered an extravascular space; thus, IGF/IGFBP forms in PD are more likely than serum forms to interact with target tissues. IGF-I and IGF-II, and IGFBPs 1-4, were readily identified by specific immunoassays and/or 125iodine-IGF ligand blotting of simultaneously obtained PD and serum samples from seven CRF children; IGFBP-3 was a major IGFBP in PD as in serum. Where quantitated, IGF and IGFBP levels in PD were approximately 10% of serum concentrations. After separation of PD and serum by size-exclusion chromatography, serum had more IGFBP-3 in 150-kilodalton (kDa) than 35-kDa fractions, while PD had far less IGFBP-3 in 150-kDa than 35-kDa fractions. Immunoblot studies revealed a major 29-kDa IGFBP-3 fragment, in addition to intact 41- and 38-kDa IGFBP-3 forms, in PD and CRF serum; the 29-kDa form predominated in the 35-kDa PD fractions. These data suggest that the 29-kDa fragment is the IGFBP-3 form most likely to modulate IGF effects on target tissues of CRF individuals.

Original languageEnglish (US)
Pages (from-to)467-473
Number of pages7
JournalPediatric Nephrology
Volume10
Issue number4
DOIs
StatePublished - 1996
Externally publishedYes

Fingerprint

Insulin-Like Growth Factor Binding Proteins
Dialysis Solutions
Insulin-Like Growth Factor Binding Protein 3
Serum
Chronic Kidney Failure
Somatomedins
Insulin-Like Growth Factor Binding Protein 1
Insulin-Like Growth Factor Binding Protein 4
Insulin-Like Growth Factor II
Insulin-Like Growth Factor I
Immunoassay
Gel Chromatography
Ligands

Keywords

  • Chronic renal failure
  • Insulin-like growth factor
  • Insulin-like growth factor binding protein
  • Peritoneal dialysate

ASJC Scopus subject areas

  • Nephrology
  • Pediatrics, Perinatology, and Child Health

Cite this

Kale, A. S., Liu, F., Hintz, R. L., Baker, B. K., Brewer, E. D., Lee, P., ... Powell, D. R. (1996). Characterization of insulin-like growth factors and their binding proteins in peritoneal dialysate. Pediatric Nephrology, 10(4), 467-473. https://doi.org/10.1007/s004670050141

Characterization of insulin-like growth factors and their binding proteins in peritoneal dialysate. / Kale, Arundhati S.; Liu, Frances; Hintz, Raymond L.; Baker, Bonita K.; Brewer, Eileen D.; Lee, Phillip; Durham, Susan K.; Powell, David R.

In: Pediatric Nephrology, Vol. 10, No. 4, 1996, p. 467-473.

Research output: Contribution to journalArticle

Kale, AS, Liu, F, Hintz, RL, Baker, BK, Brewer, ED, Lee, P, Durham, SK & Powell, DR 1996, 'Characterization of insulin-like growth factors and their binding proteins in peritoneal dialysate', Pediatric Nephrology, vol. 10, no. 4, pp. 467-473. https://doi.org/10.1007/s004670050141
Kale, Arundhati S. ; Liu, Frances ; Hintz, Raymond L. ; Baker, Bonita K. ; Brewer, Eileen D. ; Lee, Phillip ; Durham, Susan K. ; Powell, David R. / Characterization of insulin-like growth factors and their binding proteins in peritoneal dialysate. In: Pediatric Nephrology. 1996 ; Vol. 10, No. 4. pp. 467-473.
@article{aa02d0ce0f8c48f38ab466216ef8c977,
title = "Characterization of insulin-like growth factors and their binding proteins in peritoneal dialysate",
abstract = "Serum insulin-like growth factors (IGFs), which circulate bound to specific IGF binding proteins (IGFBPs), must exit the intravascular space before acting on target tissues. Little is known about the nature of IGF/IGFBPs in extravascular fluids of patients with chronic renal failure (CRF). Peritoneal dialysate (PD) was studied since, after a short incubation, PD contains proteins which have entered an extravascular space; thus, IGF/IGFBP forms in PD are more likely than serum forms to interact with target tissues. IGF-I and IGF-II, and IGFBPs 1-4, were readily identified by specific immunoassays and/or 125iodine-IGF ligand blotting of simultaneously obtained PD and serum samples from seven CRF children; IGFBP-3 was a major IGFBP in PD as in serum. Where quantitated, IGF and IGFBP levels in PD were approximately 10{\%} of serum concentrations. After separation of PD and serum by size-exclusion chromatography, serum had more IGFBP-3 in 150-kilodalton (kDa) than 35-kDa fractions, while PD had far less IGFBP-3 in 150-kDa than 35-kDa fractions. Immunoblot studies revealed a major 29-kDa IGFBP-3 fragment, in addition to intact 41- and 38-kDa IGFBP-3 forms, in PD and CRF serum; the 29-kDa form predominated in the 35-kDa PD fractions. These data suggest that the 29-kDa fragment is the IGFBP-3 form most likely to modulate IGF effects on target tissues of CRF individuals.",
keywords = "Chronic renal failure, Insulin-like growth factor, Insulin-like growth factor binding protein, Peritoneal dialysate",
author = "Kale, {Arundhati S.} and Frances Liu and Hintz, {Raymond L.} and Baker, {Bonita K.} and Brewer, {Eileen D.} and Phillip Lee and Durham, {Susan K.} and Powell, {David R.}",
year = "1996",
doi = "10.1007/s004670050141",
language = "English (US)",
volume = "10",
pages = "467--473",
journal = "Pediatric Nephrology",
issn = "0931-041X",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Characterization of insulin-like growth factors and their binding proteins in peritoneal dialysate

AU - Kale, Arundhati S.

AU - Liu, Frances

AU - Hintz, Raymond L.

AU - Baker, Bonita K.

AU - Brewer, Eileen D.

AU - Lee, Phillip

AU - Durham, Susan K.

AU - Powell, David R.

PY - 1996

Y1 - 1996

N2 - Serum insulin-like growth factors (IGFs), which circulate bound to specific IGF binding proteins (IGFBPs), must exit the intravascular space before acting on target tissues. Little is known about the nature of IGF/IGFBPs in extravascular fluids of patients with chronic renal failure (CRF). Peritoneal dialysate (PD) was studied since, after a short incubation, PD contains proteins which have entered an extravascular space; thus, IGF/IGFBP forms in PD are more likely than serum forms to interact with target tissues. IGF-I and IGF-II, and IGFBPs 1-4, were readily identified by specific immunoassays and/or 125iodine-IGF ligand blotting of simultaneously obtained PD and serum samples from seven CRF children; IGFBP-3 was a major IGFBP in PD as in serum. Where quantitated, IGF and IGFBP levels in PD were approximately 10% of serum concentrations. After separation of PD and serum by size-exclusion chromatography, serum had more IGFBP-3 in 150-kilodalton (kDa) than 35-kDa fractions, while PD had far less IGFBP-3 in 150-kDa than 35-kDa fractions. Immunoblot studies revealed a major 29-kDa IGFBP-3 fragment, in addition to intact 41- and 38-kDa IGFBP-3 forms, in PD and CRF serum; the 29-kDa form predominated in the 35-kDa PD fractions. These data suggest that the 29-kDa fragment is the IGFBP-3 form most likely to modulate IGF effects on target tissues of CRF individuals.

AB - Serum insulin-like growth factors (IGFs), which circulate bound to specific IGF binding proteins (IGFBPs), must exit the intravascular space before acting on target tissues. Little is known about the nature of IGF/IGFBPs in extravascular fluids of patients with chronic renal failure (CRF). Peritoneal dialysate (PD) was studied since, after a short incubation, PD contains proteins which have entered an extravascular space; thus, IGF/IGFBP forms in PD are more likely than serum forms to interact with target tissues. IGF-I and IGF-II, and IGFBPs 1-4, were readily identified by specific immunoassays and/or 125iodine-IGF ligand blotting of simultaneously obtained PD and serum samples from seven CRF children; IGFBP-3 was a major IGFBP in PD as in serum. Where quantitated, IGF and IGFBP levels in PD were approximately 10% of serum concentrations. After separation of PD and serum by size-exclusion chromatography, serum had more IGFBP-3 in 150-kilodalton (kDa) than 35-kDa fractions, while PD had far less IGFBP-3 in 150-kDa than 35-kDa fractions. Immunoblot studies revealed a major 29-kDa IGFBP-3 fragment, in addition to intact 41- and 38-kDa IGFBP-3 forms, in PD and CRF serum; the 29-kDa form predominated in the 35-kDa PD fractions. These data suggest that the 29-kDa fragment is the IGFBP-3 form most likely to modulate IGF effects on target tissues of CRF individuals.

KW - Chronic renal failure

KW - Insulin-like growth factor

KW - Insulin-like growth factor binding protein

KW - Peritoneal dialysate

UR - http://www.scopus.com/inward/record.url?scp=0029744518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029744518&partnerID=8YFLogxK

U2 - 10.1007/s004670050141

DO - 10.1007/s004670050141

M3 - Article

VL - 10

SP - 467

EP - 473

JO - Pediatric Nephrology

JF - Pediatric Nephrology

SN - 0931-041X

IS - 4

ER -